This section of the review has the goal to provide an overview of therapeutic options currently in clinical trials for mitochondrial diseases, with a particular focus on those molecules promoting mitochondrial biogenesis, a key process involving PGC1α (summarized in Table 1). The gene discussed is PPARGC1A; the disease is inborn mitochondrial metabolism disorder.